Upstream Bio will use its IPO haul to continue clinical testing of verekitug, which it contends could be a better treatment option for severe asthma compared to a commercialized Amgen and ...
£;Ã0 ae¥ÖCªHÍê P ‰1nè _ þýU`ìnˆu\Ï÷¥~æÿÇ3U7ÈûbëX–Mðó J {ôYK¶´«»#ïÖ)ïÖ H4IH @ àÌкªr ¼o’¼$xQèÕ–ýŸ®Öô/ä ÛYHü ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback